The short answer is that combining these treatments lacks clinical support and introduces unnecessary risksand there are evidence-based alternatives that work better
7 Department of Reproductive Medicine, Binzhou Medical University Hospital, Binzhou, Shandong, Peoples Republic of China *These authors contributed equally to this work Correspondence: Lei Zhang, Department of Endocrinology and Metabolism, Binzhou Medical University Hospital, Binzhou, Shandong, Peoples Republic of China, Email [email protected] Background: GLP-1 receptor agonists (GLP-1 RA) have been proven to treat several metabolic diseases
The choice between these agents ultimately hinges on individual patient preferences, tolerability, and therapeutic goals
doi: 10.1002/mco2.156 198 OtteCGoldSMPenninxBWParianteCMEtkinAFavaMet al